meRfi®-GM
Development of Gut Microbiota & Neonates / Early Childhood
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Bacteroides fragilis uses a range of binding proteins to capture extracellular Human Milk Oligosaccharides (HMOs) and perform their metabolism intracellularly, while using the sialidase NanH (BF1806) and other enzymes in HMO PUL 1 as a central enzymatic system for depolymerization of HMOs.
Mice develop fewer CD4+ CD25+ FOXP3 high Treg (peripherally induced) and less [IgA](brain://G5B_EDmzgE6KDMZygCXNlQ/SecretedImmunoglobulinASIgAIgA…
References (Sources)
- Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome
- Diversity of bifidobacteria within the infant gut microbiota
- Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis
- Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma
- Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome
- Strain-level analysis of mother-to-child bacterial transmission during the first few months of life
- Temporal development of the infant gut microbiome